Iofetamine (123 I)

Iofetamine (123I) is a radiopharmaceutical agent used for myocardial perfusion imaging. It is a radiolabeled form of the neurotransmitter acetylcholine, which is involved in the transmission of nerve signals in the heart and other organs. Iofetamine is taken up by the myocardium and can be used to assess the extent of myocardial ischemia and perfusion. It is also used to diagnose coronary artery disease, evaluate the amount of viable myocardium, and assess the effectiveness of treatment. The radiation emitted by this agent is detected by a gamma camera, allowing physicians to view the distribution of the tracer in the heart.

Iofetamine (123I), also known by brand names like Perfusamine, SPECTamine, or N-isopropyl-(123I)-p-iodoamphetamine (IMP), is a radiopharmaceutical drug used in nuclear medicine for diagnostic imaging of the brain [Wikipedia, Iodine (123I) iofetamine]. Here's a closer look at its properties and applications:

Function:

It combines two key components:

  • Iodine-123 (123I): A radioactive isotope of iodine with a short half-life (around 13 hours) that emits gamma rays suitable for imaging purposes.
  • Iofetamine: An amphetamine analog molecule that can readily cross the blood-brain barrier due to its lipophilic (fat-soluble) properties.

How it Works:

  1. Iofetamine (123I) is injected intravenously.
  2. Due to its structure, iofetamine readily crosses the blood-brain barrier and reaches brain tissue.
  3. Brain regions with higher blood flow take up more of the radiopharmaceutical.
  4. The radioactive iodine-123 emits gamma rays which are then detected by a special gamma camera.
  5. A computer translates the gamma ray information into an image, allowing visualization of cerebral blood flow.

Applications:

Iofetamine (123I) is primarily used in a diagnostic imaging technique called single-photon emission computed tomography (SPECT) for the brain. A SPECT imaging procedure with Iofetamine (123I) helps evaluate blood flow in the brain and can be useful for diagnosing or monitoring various conditions, including:

  • Non-lacunar stroke: Helps differentiate between different types of stroke by identifying areas of reduced blood flow.
  • Complex partial seizures: Helps pinpoint areas of the brain where seizures may be originating by showing increased blood flow during seizure activity.
  • Early diagnosis of Alzheimer's disease: May show reduced blood flow in specific brain regions affected by the disease.

Important Considerations:

  • Due to the radioactive nature of iodine-123, there are some limitations to its use:
    • Pregnant and breastfeeding women are typically excluded due to potential risks to the developing baby.
    • It may not be suitable for everyone, especially those with kidney problems, allergies to iodine, or certain heart conditions.
  • There can be potential side effects associated with the procedure, such as headache, dizziness, or nausea. However, these are usually mild and temporary.
Anatomical Therapeutic Chemical Classification
V - Various
QV09 Diagnostic radiopharmaceuticals
QV09A - Central nervous system
QV09AB Iodine (123I) compounds
External Links